Translation of SOX10 3' untranslated region causes a complex severe neurocristopathy by generation of a deleterious functional domain.
暂无分享,去创建一个
J. Lupski | M. Wegner | Y. Goto | N. Inoue | Li-hua Yu | Ken Inoue | Ryoko Yamamoto | Tomoko Ohyama | Yosuke Sakuragi
[1] M. Wegner,et al. Prolonged Sox4 Expression in Oligodendrocytes Interferes with Normal Myelination in the Central Nervous System , 2007, Molecular and Cellular Biology.
[2] T. Shimotake,et al. Neuroglial disorders of central and peripheral nervous systems in a patient with Hirschsprung's disease carrying allelic SOX10 truncating mutation. , 2007, Journal of pediatric surgery.
[3] M. Wegner,et al. From stem cells to neurons and glia: a Soxist's view of neural development , 2005, Trends in Neurosciences.
[4] J. Lupski,et al. Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. , 2005, American journal of human genetics.
[5] J. Lupski,et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations , 2004, Nature Genetics.
[6] P. Tam,et al. Analysis of SOX10 mutations identified in Waardenburg‐Hirschsprung patients: Differential effects on target gene regulation , 2003, Journal of cellular biochemistry.
[7] Ron D. Appel,et al. ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..
[8] K. Karplus,et al. Hidden Markov models that use predicted local structure for fold recognition: Alphabets of backbone geometry , 2003, Proteins.
[9] J. Lupski,et al. Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg–Hirschsprung disease: Phenotypes linked by SOX10 mutation , 2002, Annals of neurology.
[10] M. Wegner,et al. Sox10 Is an Active Nucleocytoplasmic Shuttle Protein, and Shuttling Is Crucial for Sox10-Mediated Transactivation , 2002, Molecular and Cellular Biology.
[11] I. Verma,et al. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism , 2002, Human Genetics.
[12] O. Dubourg,et al. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. , 2001, Human molecular genetics.
[13] P. Tam,et al. Novel mutations of SOX10 suggest a dominant negative role in Waardenburg-Shah syndrome , 2001, Journal of medical genetics.
[14] C. Lacroix,et al. Peripheral neuropathy with hypomyelination, chronic intestinal pseudo‐obstruction and deafness: A developmental “neural crest syndrome” related to a SOX10 mutation , 2000, Annals of neurology.
[15] M. Wegner,et al. The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. , 2000, Nucleic acids research.
[16] A. Munnich,et al. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. , 2000, American journal of human genetics.
[17] M. Wegner,et al. Protein Zero Gene Expression Is Regulated by the Glial Transcription Factor Sox10 , 2000, Molecular and Cellular Biology.
[18] J. Lupski,et al. Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation , 1999, Annals of neurology.
[19] M. Wegner,et al. Functional Analysis of Sox10 Mutations Found in Human Waardenburg-Hirschsprung Patients* , 1998, The Journal of Biological Chemistry.
[20] Giovanni Romeo,et al. SOX10 mutations in patients with Waardenburg-Hirschsprung disease , 1998, Nature Genetics.
[21] M. Wegner,et al. Sox10, a Novel Transcriptional Modulator in Glial Cells , 1998, The Journal of Neuroscience.
[22] M. Wegner,et al. Identification of the Nuclear Localization Signal of the POU Domain Protein Tst-1/Oct6* , 1996, The Journal of Biological Chemistry.
[23] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.